BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11122547)

  • 21. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
    Fredrickson BJ; Turner NA; Kleiman NS; Graziadei N; Maresh K; Mascelli MA; Effron MB; McIntire LV
    Circulation; 2000 Mar; 101(10):1122-9. PubMed ID: 10715258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
    Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
    Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of aspirin, ticlopidine and their low-dose combination on platelet aggregability in acute ischemic stroke: a short duration follow-up study.
    Akyuz A; Bolayir E; Dener S; Topalkara K; Topaktas S
    Eur J Neurol; 1999 Jan; 6(1):57-61. PubMed ID: 10209351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone.
    Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J
    Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
    Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.
    Tanigawa T; Nishikawa M; Kitai T; Ueda Y; Okinaka T; Makino K; Ito M; Isaka N; Ikeda Y; Shiku H; Nakano T
    Am J Cardiol; 2000 May; 85(9):1054-9. PubMed ID: 10781751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.
    Peters AJ; Borries M; Gradaus F; Jax TW; Schoebel FC; Strauer BE
    J Thromb Thrombolysis; 2001 Dec; 12(3):263-72. PubMed ID: 11981109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reduction of in-hospital complications after elective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin].
    Reffelmann T; vom Dahl J; Hendriks F; Klues HG; Hanrath P
    Z Kardiol; 1998 Nov; 87(11):872-80. PubMed ID: 9885180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
    Marco J; Ariëns RA; Fajadet J; Bossi IM; Marco I; Bernies M; Romano SM; Donatelli F; Brambilla GM; Somalvico F; Mari D; Gregorini L
    Am J Cardiol; 2000 Mar; 85(5):527-31. PubMed ID: 11078261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro.
    Kleiman NS; Graziadei N; Jordan RE; Lance ET; Fischer A; Maresh K; Edwards A; Mascelli MA
    J Thromb Thrombolysis; 2000 Jan; 9(1):29-36. PubMed ID: 10590186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
    Han YL; Su QF; Li Y; Kang J; Yan CH; Wang SL
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):635-8. PubMed ID: 17074146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
    J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin.
    Helft G; Osende JI; Worthley SG; Zaman AG; Rodriguez OJ; Lev EI; Farkouh ME; Fuster V; Badimon JJ; Chesebro JH
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2316-21. PubMed ID: 11031221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
    Johnson GJ; Sharda AV; Rao GH; Ereth MH; Laxson DD; Owen WG
    Clin Appl Thromb Hemost; 2012; 18(2):140-9. PubMed ID: 22009986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.